GGrantIndex
← Leaderboards

Steven E Arnold

Massachusetts General Hospital

Google Scholar ↗PubMed ↗ORCID ↗
$15,876,281
Attributed
$22,841,738
Total exposure
18
Grants
12
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $6.5M · FY2005–25
$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$22,841,738 · 18

By mechanism

R01$12,096,717 · 6
RF1$5,057,382 · 2
P30$2,324,327 · 2
U19$1,488,394 · 2
R21$954,840 · 2
P01$773,750 · 2

Top collaborators

Most similar at Massachusetts General Hospital

Same institution · by research overlap

Others in their field

Top investigators on “Alzheimer&Apos”

Research focus

Alzheimer&AposS DiseaseSynapsesPathologyTau ProteinsNeuropathologyImpaired CognitionBiological MarkersBrainParticipantSamplingCohortMetabolicPathway InteractionsInterestPlasmaFunctional DisorderCognitiveCognitionDementiaCerebrospinal FluidResponseProteinsAmyloid

Grant awards (52)

EFFECTS OF STRESS, ALLOSTATIC LOAD, AND SOCIAL INEQUITIES ON BRAIN STRUCTURE, FUNCTION, AND COGNITION IN THE EARLY-TO-MIDLIFE TRANSITION$823,777
U19 · FY2025 · AG · contact PI
Biomarker Core$409,555
P30 · FY2025 · AG · contact PI
Biomarkers Core (Core E)$157,153
P01 · FY2025 · AG · contact PI
Biomarker Core$378,998
P30 · FY2024 · AG · contact PI
Biomarkers Core (Core E)$161,841
P01 · FY2024 · AG · contact PI
EFFECTS OF STRESS, ALLOSTATIC LOAD, AND SOCIAL INEQUITIES ON BRAIN STRUCTURE, FUNCTION, AND COGNITION IN THE EARLY-TO-MIDLIFE TRANSITION$313,084
U19 · FY2023 · AG · contact PI
Biomarker Core$301,948
P30 · FY2023 · AG · contact PI
Biomarkers Core (Core E)$150,081
P01 · FY2023 · AG · contact PI
The Massachusetts and Yale ADRC Collaborative Proteomic Biofluid Biomarker Discovery Program$400,779
R01 · FY2022 · AG · contact PI
Biomarker Core$301,948
P30 · FY2022 · AG · contact PI
EFFECTS OF STRESS, ALLOSTATIC LOAD, AND SOCIAL INEQUITIES ON BRAIN STRUCTURE, FUNCTION, AND COGNITION IN THE EARLY-TO-MIDLIFE TRANSITION$175,806
U19 · FY2022 · AG · contact PI
Biomarkers Core (Core E)$164,674
P01 · FY2022 · AG · contact PI
The Massachusetts and Yale ADRC Collaborative Proteomic Biofluid Biomarker Discovery Program$750,020
R01 · FY2021 · AG · contact PI
Biomarker Core$319,724
P30 · FY2021 · AG · contact PI
EFFECTS OF STRESS, ALLOSTATIC LOAD, AND SOCIAL INEQUITIES ON BRAIN STRUCTURE, FUNCTION, AND COGNITION IN THE EARLY-TO-MIDLIFE TRANSITION$175,727
U19 · FY2021 · AG · contact PI
The Massachusetts and Yale ADRC Collaborative Proteomic Biofluid Biomarker Discovery Program$762,826
R01 · FY2020 · AG · contact PI
Biomarker Core$318,366
P30 · FY2020 · AG · contact PI
Biomarkers to enable ASO prevention trials in genetic prion disease carriers$212,829
R21 · FY2020 · TR · contact PI
Biomarkers Core (Core E)$140,001
P01 · FY2020 · AG · contact PI
The Massachusetts and Yale ADRC Collaborative Proteomic Biofluid Biomarker Discovery Program$761,448
R01 · FY2019 · AG · contact PI
Biomarker Core$293,788
P30 · FY2019 · AG · contact PI
Biomarkers to enable ASO prevention trials in genetic prion disease carriers$271,761
R21 · FY2019 · TR · contact PI
Linking peripheral and brain insulin resistance to AD neuropathology and cognition$3,800,482
RF1 · FY2018 · AG
CMP3: A CSF Multiple Pathophysiology Panel for Clinical Trials in Alzheimer's Disease$1,256,900
RF1 · FY2018 · AG · contact PI
The Massachusetts and Yale ADRC Collaborative Proteomic Biofluid Biomarker Discovery Program$775,203
R01 · FY2018 · AG · contact PI
Mechanisms linking insulin resistance to brain structure, pathology, and function$617,586
R01 · FY2018 · NS
Mechanisms linking insulin resistance to brain structure, pathology, and function$621,171
R01 · FY2017 · NS
Assessment of Brain Insulin Resistance in Alzheimer's Disease with Insulin Clamp$213,750
R21 · FY2017 · AG · contact PI
Mechanisms linking insulin resistance to brain structure, pathology, and function$638,544
R01 · FY2016 · NS
Assessment of Brain Insulin Resistance in Alzheimer's Disease with Insulin Clamp$256,500
R21 · FY2016 · AG · contact PI
Mechanisms linking insulin resistance to brain structure, pathology, and function$649,507
R01 · FY2015 · NS
Targeted Proteomics of Resilient Cognition in Aging$264,211
R01 · FY2015 · AG · contact PI
Targeted Proteomics of Resilient Cognition in Aging$256,386
R01 · FY2015 · AG · contact PI
Mechanisms linking insulin resistance to brain structure, pathology, and function$670,619
R01 · FY2014 · NS
Targeted Proteomics of Resilient Cognition in Aging$438,402
R01 · FY2014 · AG · contact PI
Targeted Proteomics of Resilient Cognition in Aging$84,800
R01 · FY2014 · AG · contact PI
Targeted Proteomics of Resilient Cognition in Aging$424,327
R01 · FY2013 · AG · contact PI
Targeted Proteomics of Resilient Cognition in Aging$505,190
R01 · FY2012 · AG · contact PI
Targeted Proteomics of Resilient Cognition in Aging$520,746
R01 · FY2011 · AG · contact PI
Neurobiology of Dysbindin in Schizophrenia and sdy Mouse$420,742
R01 · FY2008 · MH · contact PI
Neurobiology of Dysbindin in Schizophrenia and sdy Mouse$438,488
R01 · FY2007 · MH · contact PI
Neurobiology of Dysbindin in Schizophrenia and sdy Mouse$418,061
R01 · FY2006 · MH · contact PI
Neurobiology of Dysbindin in Schizophrenia and sdy Mouse$465,200
R01 · FY2005 · MH
OLFACTORY NEURODEVELOPMENTAL PATHOLOGY IN SCHIZOPHRENIA$237,750
R01 · FY2002 · MH
MAP2 AND THE NEURONAL CYTOSKELETON IN SCHIZOPHRENIA$161,095
R01 · FY2002 · MH
PLASTICITY IN STIMULUS ENCODING CIRCUITS IN SCHIZOPHRENIA$0
P50 · FY2002 · MH
OLFACTORY NEURODEVELOPMENTAL PATHOLOGY IN SCHIZOPHRENIA$237,750
R01 · FY2001 · MH
MAP2 AND THE NEURONAL CYTOSKELETON IN SCHIZOPHRENIA$156,556
R01 · FY2001 · MH
CLINICAL RESEARCH EDUCATION IN MENTAL HEALTH$146,328
R25 · FY2001 · MH
PLASTICITY IN STIMULUS ENCODING CIRCUITS IN SCHIZOPHRENIA$0
P50 · FY2001 · MH
OLFACTORY NEURODEVELOPMENTAL PATHOLOGY IN SCHIZOPHRENIA$267,313
R01 · FY2000 · MH
MAP2 AND THE NEURONAL CYTOSKELETON IN SCHIZOPHRENIA$151,997
R01 · FY2000 · MH